Pharmaceutical Services

Pharmaceutical Technology Transfer Services for Generic Drug Products

Helping pharmaceutical companies transfer products from site to site, R&D to manufacturing, or sponsor to CMO — with reduced technical risk, smoother validation, and faster commercial readiness.

Technology transfer is one of the most critical stages in a pharmaceutical product lifecycle. A poorly managed transfer can lead to scale-up failure, repeated trial batches, validation delays, OOS results, supply interruption, and regulatory setbacks. KH Scientific Solutions supports companies with practical, industry-driven expertise to make technology transfer structured, documented, risk-based, and commercially successful.

Site-to-Site Transfer

Support for transferring marketed products between manufacturing sites or CMOs.

Scale-Up & Validation Readiness

From trial and engineering batches to exhibit and PPQ batches.

Technical Gap Analysis

Assessment of equipment, process, materials, documents, and facility readiness.

Commercial Batch Continuity

Reducing failure risks that may delay launch, supply, or market availability.

Technology Transfer Is a High-Risk Execution Project — Not a Simple Documentation Exercise

A successful technology transfer requires transferring both documented knowledge and practical know-how. The Receiving Unit must be able to reproduce the same product quality, process performance, control strategy, and regulatory expectations under its own equipment, facility, people, and supply chain conditions.

What Can Go Wrong
  • Equipment geometry or scale mismatch
  • Different operating principles between sites
  • API particle size or moisture sensitivity
  • Excipient or vendor variability
  • CPP mismatch leading to dissolution, assay, CU, or stability failure
  • Analytical method transfer failure
  • OOS results during validation
  • Incomplete development history or poor documentation
  • Poor coordination between R&D, Production, QC, QA, Regulatory, and Supply Chain
What KH Helps You Prevent
  • Repeated trial batch cost
  • Delayed validation
  • Failed exhibit or PPQ batches
  • Regulatory submission delays
  • Commercial launch delay
  • Supply interruption
  • Market shortage risk
  • Uncontrolled post-approval changes

End-to-End Support Across the Technology Transfer Lifecycle

Structured support from initial feasibility through post-transfer commercial monitoring.

Initial Technical Assessment & Due Diligence

We assess the product, formula, process, site readiness, regulatory status, and transfer feasibility before execution begins.

Gap Analysis Between Sending and Receiving Units

We compare equipment, batch size, process parameters, facility capability, documentation, analytical readiness, and quality systems.

Technology Transfer Protocol & Master Plan

We help define the transfer strategy, stages, responsibilities, acceptance criteria, timelines, and success measures.

Formula, Process & Control Strategy Review

We review CQAs, CMAs, CPPs, manufacturing formula, processing instructions, and historical development rationale.

Scale-Up and Trial / Engineering Batch Support

We support trial batch planning, execution, parameter optimisation, deviation analysis, and preparation for formal GMP batches.

Analytical Method Transfer Coordination

We support transfer of analytical procedures between laboratories to ensure QC consistency and reliable release testing.

Validation and PPQ Readiness

We help prepare for exhibit, registration, validation, and commercial batches with focus on process robustness.

Troubleshooting During Transfer

We support root cause analysis for dissolution failure, assay variation, coating failure, stability issues, OOS results, and process deviations.

Technology Transfer Report & Post-Transfer Monitoring

We support final reporting, lessons learned, and continued process verification during the early commercial lifecycle.

Technology Transfer Scenarios We Handle

We support transfers across all stages of the pharmaceutical development and commercial lifecycle.

01

R&D to Commercial Manufacturing

Moving a product from laboratory or pilot development into full-scale GMP production at the manufacturing site.

02

Site-to-Site Transfer

Transferring a marketed or pipeline product between two manufacturing facilities within or across organisations.

03

Sponsor to CMO Transfer

Handing over product, process, and analytical responsibility to a contract manufacturing organisation.

04

CMO to CMO Transfer

Transitioning manufacturing responsibility from one CMO to another due to capacity, strategy, or supply chain reasons.

05

Lab Scale to Pilot Scale

Moving from small-scale R&D batches to pilot-scale manufacturing to evaluate scalability and process robustness.

06

Pilot to Validation Batch

Preparing for exhibit and PPQ batches based on confirmed process parameters and defined acceptance criteria.

07

Validation to Routine Commercial

Ensuring commercial batch consistency after successful PPQ, with CPV and early post-launch monitoring in place.

08

Analytical Method Transfer

Transferring validated analytical procedures between QC laboratories with equivalent performance qualification.

09

Post-Approval Site Change

Managing regulatory and technical requirements for manufacturing site variation submissions after initial approval.

A Structured Workflow to Reduce Transfer Failure

Six defined stages — from feasibility through commercial stabilisation.

01

Evaluate

Product review, transfer objective, due diligence, and feasibility assessment.

02

Plan

Gap analysis, cross-functional responsibilities, transfer protocol, timelines, and success criteria.

03

Prepare

Knowledge transfer, document review, equipment fitment, material readiness, and risk assessment.

04

Execute

Trial / engineering batches, exhibit batches, analytical method transfer, and process optimisation.

05

Validate

PPQ / process validation support, deviation handling, and data assessment against predefined acceptance criteria.

06

Stabilize

Technology transfer report, continued process verification, early commercial monitoring, and post-transfer improvement.

Key Deliverables You Can Expect

Documented outputs that support your regulatory submission, batch records, and post-transfer monitoring.

Technology Transfer Gap Assessment
Technology Transfer Protocol / Master Plan
Product Development Report Review
Master Formula / Manufacturing Formula Review
Batch Manufacturing Record Review or Preparation
Risk Assessment Report
CQA / CPP / CMA Mapping
Analytical Method Transfer Protocol / Report Support
Trial / Engineering Batch Technical Report
Process Validation / PPQ Support
Deviation and Troubleshooting Reports
Technology Transfer Summary Report
Post-Transfer Monitoring Recommendations

The Business Value: Fewer Surprises Between Development and Commercial Manufacturing

A well-managed technology transfer protects commercial timelines, reduces batch failure risk, improves manufacturing robustness, and supports regulatory confidence.

01

Faster Commercial Launch

Move from development or site transfer to commercial readiness with fewer delays.

02

Reduced Failed Batch Risk

Identify technical gaps before they become failed trial, exhibit, or PPQ batches.

03

Lower Repeated Trial Cost

Avoid unnecessary repeated experiments caused by poor knowledge transfer.

04

Smoother Validation

Enter validation with stronger process understanding and clearer acceptance criteria.

05

Improved Supply Continuity

Support site mobility, CMO transfer, and manufacturing continuity.

06

Reduced Regulatory Risk

Build a documented, risk-based transfer package that supports inspections, variations, and lifecycle management.

Who Needs Technology Transfer Support?

  • Generic pharmaceutical companies transferring products to a new site
  • Companies working with CMOs or planning CMO transfers
  • Start-up or mid-size pharma companies without a strong internal development team
  • Companies facing scale-up or validation failure
  • Companies preparing a site variation or manufacturing site change
  • Companies transferring analytical methods between laboratories
  • Companies launching new products from R&D into commercial manufacturing
  • Companies needing external formulation, analytical, QA, and regulatory alignment

Why KH Scientific Solutions?

KH Scientific Solutions combines formulation development, analytical understanding, regulatory awareness, manufacturing experience, troubleshooting capability, and practical industry execution. We help companies understand what must be transferred, what can fail, what must be controlled, and what must be documented to make the Receiving Unit ready for routine manufacturing.

  • Real-world pharmaceutical product development experience
  • Integrated formulation, analytical, regulatory, and manufacturing support
  • Practical experience with generic drug development and scale-up
  • Coordination across R&D, QC, QA, Production, Regulatory, and Supply Chain
  • Focus on technical risk reduction and commercial readiness
  • Support across MENA and GCC pharmaceutical markets

Frequently Asked Questions

What is pharmaceutical technology transfer?

Pharmaceutical technology transfer is the structured and documented transfer of product, process, analytical method, and manufacturing knowledge from a Sending Unit to a Receiving Unit so the product can be reproduced with consistent quality and regulatory compliance.

When does a pharmaceutical company need technology transfer support?

Companies need technology transfer support when moving a product from R&D to manufacturing, transferring production between sites, working with a CMO, scaling up from pilot to commercial batch size, or transferring analytical methods between laboratories.

What are the main risks during technology transfer?

Common risks include equipment mismatch, process parameter differences, material variability, poor documentation, analytical method transfer failure, dissolution or assay failure, OOS results, validation delays, and regulatory issues.

How does KH Scientific Solutions reduce technology transfer failure?

We perform technical gap analysis, review formula and process understanding, assess equipment and facility readiness, identify CQAs and CPPs, support trial and validation batches, coordinate analytical method transfer, and provide troubleshooting support.

Do you support CMO technology transfer?

Yes. KH Scientific Solutions supports sponsor-to-CMO and CMO-to-CMO technology transfer by helping align technical documents, process requirements, analytical methods, validation expectations, and commercial manufacturing readiness.

Can you support technology transfer for already marketed products?

Yes. We support site-to-site transfer, post-approval manufacturing site changes, process troubleshooting, validation readiness, and product lifecycle transfer activities.

Planning a Product Transfer? Let's Assess the Risks Before They Become Batch Failures.

Whether you are transferring a product from R&D to manufacturing, moving production to a new site, working with a CMO, or preparing validation batches, KH Scientific Solutions can help you evaluate risks, close technical gaps, and build a practical transfer roadmap.

Share your transfer challenge. Our team will review your request and contact you to discuss the most suitable support approach.